Muscular Dystrophy Drugs Face New FDA Questions

Hopes are dimming that the drug industry will be able to quickly deliver a treatment for one of the most keenly researched diseases of recent years—an inherited muscle-wasting disorder called Duchenne muscular dystrophy.